SAN DIEGO: Aethlon Medical, Inc. (OTCBB:AEMD) has disclosed that it will provide Hemopurifier® therapy under FDA compassionate use access provisions to support potential requests by qualified physicians and institutes that may seek to treat ebola virus infection in the United States.
- THE EDITORIAL TEAM
- Health Security
- Posted On